Workflow role
CT image networking, processing, enhancement, triage, measurement, or professional workflow support.
exact submission · checked 2026-09-04This is a submission-anchored intended-use summary, not a local acceptance result.
FDA-cleared profile
Aidoc Medical, Ltd.
BriefCase provides computer-assisted triage and notification for suspected intracranial hemorrhage on noncontrast head CT and or large-vessel occlusion on head CTA in parallel with standard care; it does not provide a primary diagnosis.
Clinical fit
Start with the authorized purpose, then verify how it fits your service line and reading workflow.
Regulatory identity
The FDA listing establishes the regulatory identity. It does not by itself establish local workflow fit, pricing, security, or performance in your environment.
Implementation
Use these fields to structure a vendor demo, security review, and implementation estimate.
Normalized from the prior exact-submission review. Confirm interface versions and local compatibility during technical evaluation.
Deployment category preserved from the prior exact-submission review; hosting region, data flow, and current commercial configuration still require vendor confirmation.
Public sources reviewed here do not establish the complete exact-release security posture, including identity, audit, encryption, retention, remote access, vulnerability management, backup, or incident response.
Training, onboarding, competency, and support commitments are commercial implementation details that require current vendor documentation.
Local acceptance testing, production monitoring, drift review, update control, and incident escalation require a current vendor and site-specific governance plan.
CT image networking, processing, enhancement, triage, measurement, or professional workflow support.
exact submission · checked 2026-09-04This is a submission-anchored intended-use summary, not a local acceptance result.
Supported CT or CTA DICOM images and the metadata required by the exact release-specific processing workflow.
exact submission · checked 2026-09-04Exact supported inputs and protocol limits must be confirmed from the complete labeling.
Processed CT image objects, measurements, notifications, or worklist outputs for professional review.
exact submission · checked 2026-09-04Output review, editing, and downstream use remain release- and site-specific.
Current vendor material is product-family context for K180647 only; exact release, enabled options, deployment, and local interoperability require confirmation.
product family · checked 2026-09-04Vendor material is not exact-release evidence unless that linkage is separately proven.
Exact local interfaces, deployment topology, security controls, downtime behavior, and support obligations remain unestablished.
exact submission · checked 2026-09-04Obtain organization-specific implementation evidence before procurement or clinical use.
Evidence
Metrics are shown only when they are tied to a source, endpoint, population, and tested product version.
Values reported in the exact-submission materials. Consult the linked source for endpoint, threshold, population, and confidence interval before comparison.
Values reported in the exact-submission materials. Consult the linked source for endpoint, threshold, population, and confidence interval before comparison.
No contextualized exact-version metric has completed evidence review. Regulatory-document values, when available, are shown above with their limitations.
Regulatory verification, validation, and labeling evidence reviewed for exact FDA submission K180647. · The labeled population and test materials for exact submission K180647; a general clinical study population is not established here.
exact submission · Tested version: BriefCase (K180647) · Sponsor or vendor studyK180647
FDA regulatory evidence is submission-specific but is not independent clinical performance evidence.
Candidate peer-reviewed literature record discovered by exact-name or identifier search. · Candidate record population; product and version linkage to K180647 was not established.
product family · Tested version: Candidate product-family record; exact FDA submission and product version linkage not established. · Independence not established1122766
Quarantined candidate evidence: do not treat this record as exact-submission performance evidence without product and version linkage review.
Candidate peer-reviewed literature record discovered by exact-name or identifier search. · Candidate record population; product and version linkage to K180647 was not established.
product family · Tested version: Candidate product-family record; exact FDA submission and product version linkage not established. · Independence not established36862835
Quarantined candidate evidence: do not treat this record as exact-submission performance evidence without product and version linkage review.
Candidate peer-reviewed literature record discovered by exact-name or identifier search. · Candidate record population; product and version linkage to K180647 was not established.
product family · Tested version: Candidate product-family record; exact FDA submission and product version linkage not established. · Independence not established41444826
Quarantined candidate evidence: do not treat this record as exact-submission performance evidence without product and version linkage review.
Candidate clinical-trial registry record discovered by exact-name or identifier search. · Candidate registry population; product and version linkage to K180647 was not established.
product family · Tested version: Candidate product-family record; exact FDA submission and product version linkage not established. · Independence not establishedNCT03018717
Quarantined candidate evidence: do not treat this record as exact-submission performance evidence without product and version linkage review.
Candidate clinical-trial registry record discovered by exact-name or identifier search. · Candidate registry population; product and version linkage to K180647 was not established.
product family · Tested version: Candidate product-family record; exact FDA submission and product version linkage not established. · Independence not establishedNCT05125705
Quarantined candidate evidence: do not treat this record as exact-submission performance evidence without product and version linkage review.
Economics and lifecycle
These are common procurement questions; unknown values remain visible until a source supports them.
No public exact-release price, license fee, subscription, contract, or implementation cost was established in this review.
CMS index context was checked, but no product-specific coverage or reimbursement determination is inferred.
Safety and lifecycle
Recall and adverse-event records are shown only after product matching. Adverse-event reports do not establish incidence or causality.
No native submission-identifier match was found in the checked openFDA radiology recall snapshot. Product-name, manufacturer, and adverse-event searches remain necessary; this does not establish that no recall or safety report exists.
Buyer worksheet
Research record
This audit distinguishes completed source review from fields that have not yet been researched.
Exact-submission ACR model-card fields were normalized under the current provenance rules; vendor and independent-study confirmation remain distinct. Exact FDA identity, indication, modality, anatomy, workflow, and limitations were reviewed using the submission as the identity anchor. Current vendor material is product-family context only. PubMed and ClinicalTrials.gov candidates remain quarantined as product-family evidence because exact submission and version linkage was not established. CMS and openFDA index context was checked. Pricing, security, deployment, reimbursement, contracted services, enabled options, and local interoperability remain unknown unless separately evidenced. Automated exact-name discovery found 20 PubMed and 6 ClinicalTrials.gov candidate records. Candidates require human product and version matching; zero candidates is not evidence that no studies exist. Native FDA recall identifiers produced 0 postmarket candidate records; 0 have been reviewed (0 published, 0 rejected) and 0 remain unreviewed.
Candidate leads remain unpublished until a human confirms the exact product and tested version.
Source classes: fda ai list, fda decision summary, acr ai central product, vendor product page, implementation documentation, reimbursement policy, peer reviewed literature, clinical trial registry, fda device recall, pubmed, clinical trials, openfda device recall
Sources
Sources accessed through 2026-09-04.
Alternatives
JLK, Inc.
Notification-only triage of suspected intracranial hemorrhage on non-contrast head CT
NICo-Lab B.V.
HALO analyzes contrast-enhanced brain CTA in the acute setting for suspected anterior-circulation large-vessel occlusion and provides notification support for emergency stroke...
AVICENNA.AI
CINA analyzes nonenhanced head CT for suspected intracranial hemorrhage and head CTA for suspected large-vessel occlusion for computer-aided triage and notification in parallel...
Harrison-AI Medical Pty, Ltd.
Annalise Enterprise prioritizes and notifies trained CT clinicians of suspected acute infarct on non-contrast brain CT for adults; it is a study-level, non-localizing worklist aid...